All In Biotech

Drug Trial Radar · NCT06108648

Efficacy of Lavender Essential Oil Chest Wraps in Infants With Bronchiolitis

Efficacy of Lavender Essential Oil Chest Wraps in Improving Cough and Respiratory Distress in Infants With Bronchiolitis: a Multicenter Randomized Controlled Trial

Last checked: Nov 19, 2026Latest source record: Mar 30, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 400 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

400

Planned (sponsor's estimate)

Start

Dec 7, 2023

Primary completion

Mar 31, 2026

Study completion Apr 30, 2026

Sponsor

Lead sponsor
University Hospital, GenevaAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 31, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, up to 11 months
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to learn if lavender essential oil chest wraps relieve cough in infants with bronchiolitis compared to standard care. Furthermore, the researchers will evaluate if breathing difficulties, nighttime awakening and impact on parents will be improved by the lavender oil chest wraps. Infants will be randomized to receive standard care with the addition of lavender oil chest wraps or to receive standard care alone. The study will take place in two locations in Switzerland, at the Geneva University Hospital and the Fribourg Cantonal Hospital.

Conditions

  • Bronchiolitis

Interventions

  • Lavender essential oil 10%, diluted in 90% olive oilDrug

    Lavender chest wrap: Before the first application pour 10-15 ml of lavender essential oil 10% evenly on the cotton cloth. Put the soaked cotton in the plastic bag, close it and put it to heat in two heating pads (2-5 minutes) so that the oil is distributed on all the fabric. Place the cotton cloth around the patient's chest. Cover the cotton cloth with a woolen fabric that is 2 cm larger than the cotton cloth.

  • ControlOther

    Standard care according to national standards.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cough frequencyTime frame: Up to 2 days

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Clinique de pediatrie, HFR Fribourg - Hopital cantonal, Switzerland

    Fribourg, Switzerland · Recruiting

  • Children's' Hospital, University Hospital of Geneva, Switzerland

    Geneva, Switzerland · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.